Detailed answers about THOR PHARMACEUTICAL ENTERPRISES LIMITED, including incorporation, status, business activity, and accounts information.
When was THOR PHARMACEUTICAL ENTERPRISES LIMITED founded?
THOR PHARMACEUTICAL ENTERPRISES LIMITED was officially incorporated on 2 October 2026 and is registered under company number 17496311. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is THOR PHARMACEUTICAL ENTERPRISES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of THOR PHARMACEUTICAL ENTERPRISES LIMITED?
THOR PHARMACEUTICAL ENTERPRISES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does THOR PHARMACEUTICAL ENTERPRISES LIMITED do?
THOR PHARMACEUTICAL ENTERPRISES LIMITED operates in the following sector: 70229 - Management consultancy activities other than financial management. This provides insight into the company's primary business activity and industry focus.
What is THOR PHARMACEUTICAL ENTERPRISES LIMITED's registered address?
The registered office address of THOR PHARMACEUTICAL ENTERPRISES LIMITED is 4 The Paddock, Beckingham, Lincoln, England, LN5 0FD. This is the official address filed with Companies House for legal and statutory correspondence.
Is THOR PHARMACEUTICAL ENTERPRISES LIMITED financially stable?
Financial accounts for THOR PHARMACEUTICAL ENTERPRISES LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.